Halip, Liliana

DrugCentral 2021 supports drug discovery and repositioning

Avram, S., Bologa, C. G., Holmes, J., Bocci, G., Wilson, T. B., Nguyen, D.-T., Curpan, R., Halip, L., Bora, A., Yang, J. J., et al. (2021) · Nucleic Acids Research

Computational Drug Discovery MethodsPharmacovigilance and Adverse Drug Reactions

Cited by 189

DrugCentral 2023 extends human clinical data and integrates veterinary drugs

Avram, S., Wilson, T. B., Curpan, R., Halip, L., Borota, A., Bora, A., Bologa, C. G., Holmes, J., Knockel, J., Yang, J. J., et al. (2023) · Nucleic Acids Research

Computational Drug Discovery MethodsPharmacovigilance and Adverse Drug Reactions

Cited by 101

Off-Patent drug repositioning

Avram, S., Curpan, R., Halip, L., Bora, A., & Oprea, T. I. (2020) · Journal of Chemical Information and Modeling

Computational Drug Discovery MethodsPharmaceutical Economics and Policy

Cited by 18

Novel drug targets in 2019

Avram, S., Halip, L., Curpan, R., & Oprea, T. I. (2020) · Nature Reviews Drug Discovery

Computational Drug Discovery MethodsScience, Research, and Medicine

Cited by 17

Novel drug targets in 2021

Avram, S., Halip, L., Curpan, R., & Oprea, T. I. (2022) · Nature Reviews Drug Discovery

Computational Drug Discovery MethodsPharmaceutical Economics and Policy

Cited by 15

Novel drug targets in 2020

Avram, S., Halip, L., Curpan, R., & Oprea, T. I. (2021) · Nature Reviews Drug Discovery

Computational Drug Discovery MethodsScience, Research, and Medicine

Cited by 13

Annotating off-label drug usage from unconventional sources

Avram, S., Halip, L., Curpan, R., Borota, A., Bora, A., & Oprea, T. I. (2022) · medRxiv

Pharmaceutical industry and healthcarePharmacovigilance and Adverse Drug Reactions

Cited by 4